Organization
Uma Borate
5 clinical trials
Clinical trial
A Randomized Double-Blind Placebo-Controlled Phase II Multi-Center Study of Inflammation Modification of Canakinumab to Prevent Leukemic Progression of Clonal Cytopenias of Unknown Significance (CCUS): IMPACT StudyStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
A Phase 1b/2 Study of TP-0903 in Patients With Acute Myeloid Leukemia and FLT3 MutationsStatus: Completed, Estimated PCD: 2021-10-13
Clinical trial
Safety and Efficacy of Dual Menin and FLT3 Inhibition in Patients With Relapsed/Refractory FLT3- Mutated Acute Myeloid Leukemia Containing a Concurrent MLL-Rearrangement or NPM1 Mutation: A Phase I (Ph I) Study of SNDX-5613 + GilteritinibStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Phase II Study of Clinical Efficacy of Venetoclax in Combination With Azacitidine in Patients With Therapy Related Myelodysplastic Syndrome (t-MDS)Status: Recruiting, Estimated PCD: 2024-12-31